CCL2 and metabolic disease: As serum MCP-1 is substantially elevated in patients with type-II diabetes and is a potent activator of CD8+ T-cells, MCP-1 may be a cause of elevated adipose tissue CD8+ T-cell activation with obesity or metabolic disease (115, 117).